15 results
8-K
EX-99.1
IVVD
Invivyd Inc
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
Leukemia) Society. “For people who develop a COVID-19 infection, today’s treatment options are not always adequate or clinically appropriate, especially
8-K
EX-99.1
86hz0gwmscd62w4m4
13 May 22
Adagio Therapeutics Reports First Quarter 2022 Financial Results
7:00am
10-K
x362 b3mij7t08hot
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
a06xcipqy kgdt
29 Sep 21
Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19
4:41pm
10-Q
5cmsvcxrd
20 Sep 21
Quarterly report
4:17pm
424B4
mfd7nnrk
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1/A
6kmd8381 50k
2 Aug 21
IPO registration (amended)
6:20am
S-1
actiudfk
16 Jul 21
IPO registration
4:56pm
DRS/A
885jnef yeq9g
28 Jun 21
Draft registration statement (amended)
12:00am
DRS
gdekw
21 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next